126 related articles for article (PubMed ID: 36526214)
1. Expression and immunogenicity of hepatitis E virus-like particles based on recombinant truncated ORF2 capsid protein.
Cao YF; Zhou YF; Zhao DY; Chang JL; Tang JG; Chang DY; Zhang XM; Wang XP
Protein Expr Purif; 2023 Mar; 203():106214. PubMed ID: 36526214
[TBL] [Abstract][Full Text] [Related]
2. Expression and Immunogenicity of SARS-CoV-2 Virus-Like Particles based on Recombinant Truncated HEV-3 ORF2 Capsid Protein.
Zhou YF; Nie JJ; Shi C; Ning K; Cao YF; Xie Y; Xiang H; Xie Q
J Microbiol Biotechnol; 2022 Oct; 32(10):1335-1343. PubMed ID: 36224764
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and Antigenicity of Rabbit Hepatitis E Virus-Like Particles Produced by Recombinant Baculoviruses.
Bai H; Kataoka M; Ami Y; Suzaki Y; Takeda N; Muramatsu M; Li TC
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452436
[TBL] [Abstract][Full Text] [Related]
4. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P
Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319
[TBL] [Abstract][Full Text] [Related]
5. Characterization of capsid protein (p495) of hepatitis E virus expressed in Escherichia coli and assembling into particles in vitro.
Zheng M; Jiang J; Zhang X; Wang N; Wang K; Li Q; Li T; Lin Q; Wang Y; Yu H; Gu Y; Zhang J; Li S; Xia N
Vaccine; 2018 Apr; 36(16):2104-2111. PubMed ID: 29544686
[TBL] [Abstract][Full Text] [Related]
6. Induction of antibody and interferon-γ production in mice immunized with virus-like particles of swine hepatitis E virus.
Song YJ; Park WJ; Lee SK; Lee JB; Park SY; Song CS; Lee SW; Seo KH; Kang YS; Song JY; Choi IS
J Vet Sci; 2014 Dec; 15(4):575-8. PubMed ID: 24690608
[TBL] [Abstract][Full Text] [Related]
7. Generation in yeast and antigenic characterization of hepatitis E virus capsid protein virus-like particles.
Simanavicius M; Tamosiunas PL; Petraityte-Burneikiene R; Johne R; Ulrich RG; Zvirbliene A; Kucinskaite-Kodze I
Appl Microbiol Biotechnol; 2018 Jan; 102(1):185-198. PubMed ID: 29143081
[TBL] [Abstract][Full Text] [Related]
8. Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus.
Mazalovska M; Kouokam JC
Viruses; 2020 Jul; 12(8):. PubMed ID: 32751441
[TBL] [Abstract][Full Text] [Related]
9. Immunization with recombinant ORF2 p551 protein protects common marmosets (Callithrix jacchus) against homologous and heterologous hepatitis E virus challenge.
Gordeychuk I; Kyuregyan K; Kondrashova A; Bayurova E; Gulyaev S; Gulyaeva T; Potemkin I; Karlsen A; Isaeva O; Belyakova A; Lyashenko A; Sorokin A; Chumakov A; Morozov I; Isaguliants M; Ishmukhametov A; Mikhailov M
Vaccine; 2022 Jan; 40(1):89-99. PubMed ID: 34836660
[TBL] [Abstract][Full Text] [Related]
10. Production of capsid proteins of rat hepatitis E virus in Escherichia coli and characterization of self-assembled virus-like particles.
Kobayashi T; Takahashi M; Ohta S; Nagashima S; Primadharsini PP; Mulyanto ; Kunita S; Murata K; Okamoto H
Virus Res; 2021 Sep; 302():198483. PubMed ID: 34146611
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and protective efficacy in rhesus monkeys of a recombinant ORF2 protein from hepatitis E virus genotype 4.
Huang WJ; Zhang HY; Harrison TJ; Lan HY; Huang GY; Wang YC
Arch Virol; 2009; 154(3):481-8. PubMed ID: 19240977
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs.
Sanford BJ; Opriessnig T; Kenney SP; Dryman BA; Córdoba L; Meng XJ
Vaccine; 2012 Sep; 30(44):6249-55. PubMed ID: 22906724
[TBL] [Abstract][Full Text] [Related]
13. Oral Vaccination with Hepatitis E Virus Capsid Protein and Immunobiotic Bacterium-Like Particles Induce Intestinal and Systemic Immunity in Mice.
Arce LP; Raya Tonetti MF; Raimondo MP; Müller MF; Salva S; Álvarez S; Baiker A; Villena J; Vizoso Pinto MG
Probiotics Antimicrob Proteins; 2020 Sep; 12(3):961-972. PubMed ID: 31630331
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice.
Deshmukh TM; Lole KS; Tripathy AS; Arankalle VA
Vaccine; 2007 May; 25(22):4350-60. PubMed ID: 17459540
[TBL] [Abstract][Full Text] [Related]
15. Specific memory B cell response and participation of CD4
Kulkarni SP; Thanapati S; Arankalle VA; Tripathy AS
Vaccine; 2016 Nov; 34(48):5895-5902. PubMed ID: 27997340
[TBL] [Abstract][Full Text] [Related]
16. A plant-based transient expression system for the rapid production of highly immunogenic Hepatitis E virus-like particles.
Mardanova ES; Takova KH; Toneva VT; Zahmanova GG; Tsybalova LM; Ravin NV
Biotechnol Lett; 2020 Nov; 42(11):2441-2446. PubMed ID: 32875477
[TBL] [Abstract][Full Text] [Related]
17. Production of a Hepatitis E Vaccine Candidate Using the Pichia pastoris Expression System.
Gupta J; Kumar A; Surjit M
Methods Mol Biol; 2022; 2412():117-141. PubMed ID: 34918244
[TBL] [Abstract][Full Text] [Related]
18. [Expression,Purification,Structure Determination and Immunogenicity Assay of Hepatitis E Virus Capsid Protein p495 Derived from Baculovirus-based Insect Cell].
Lin Q; Jiang J; Li T; Zhang Y; Zhang Z; Zheng M; Wang K; Zheng Q; Yu H; Gu Y; Xia N; Li S
Bing Du Xue Bao; 2016 May; 32(3):342-8. PubMed ID: 29963821
[TBL] [Abstract][Full Text] [Related]
19. Design and immunogenicity analysis of the combined vaccine against zoonotic hepatitis E and foot-and-mouth disease.
Liu Z; Behloul N; Baha S; Wei W; Shi R; Meng J
Vaccine; 2019 Oct; 37(46):6922-6930. PubMed ID: 31604580
[TBL] [Abstract][Full Text] [Related]
20. Immunization of human hepatitis E viruses conferred protection against challenge by a camel hepatitis E virus.
Guo Y; Yang F; Xu X; Feng M; Liao Y; He Z; Takeda N; Muramatsu M; Li Q; Li TC
Vaccine; 2020 Oct; 38(46):7316-7322. PubMed ID: 32980200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
